$ABBV Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AbbVie Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AbbVie Inc.. Get notifications about new insider transactions in AbbVie Inc. for free.
Page: < prev 1 2 3 4 5 6 7 8 ... 9 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 12 2017 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Buy | M | 24.21 | 4,800 | 116,199 | 93,099 | 88.3 K to 93.1 K (+5.44 %) |
| Sep 12 2017 | ABBV | AbbVie Inc. | Schumacher Laura J | Executive Vice Pres ... | Gift | G | 0.00 | 2,093 | 0 | 105,732 | 107.8 K to 105.7 K (-1.94 %) |
| Aug 08 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Option Exercise | M | 51.42 | 193,131 | 9,930,796 | 0 | |
| Aug 08 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Sell | S | 71.03 | 1,200 | 85,236 | 276,492 | 277.7 K to 276.5 K (-0.43 %) |
| Aug 08 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Sell | S | 71.01 | 9,618 | 682,974 | 277,692 | 287.3 K to 277.7 K (-3.35 %) |
| Aug 08 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Sell | S | 71.04 | 446 | 31,682 | 287,310 | 287.8 K to 287.3 K (-0.15 %) |
| Aug 08 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Sell | S | 71.02 | 3,158 | 224,281 | 287,756 | 290.9 K to 287.8 K (-1.09 %) |
| Aug 08 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Sell | S | 71.04 | 2,602 | 184,846 | 290,914 | 293.5 K to 290.9 K (-0.89 %) |
| Aug 08 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Sell | S | 71.05 | 1,100 | 78,150 | 293,516 | 294.6 K to 293.5 K (-0.37 %) |
| Aug 08 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Sell | S | 71.00 | 157,163 | 11,158,573 | 294,616 | 451.8 K to 294.6 K (-34.79 %) |
| Aug 08 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Sell | S | 71.06 | 1,800 | 127,908 | 451,779 | 453.6 K to 451.8 K (-0.40 %) |
| Aug 08 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Sell | S | 71.02 | 1,153 | 81,880 | 453,579 | 454.7 K to 453.6 K (-0.25 %) |
| Aug 08 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Sell | S | 71.05 | 6,200 | 440,510 | 454,732 | 460.9 K to 454.7 K (-1.35 %) |
| Aug 08 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Sell | S | 71.07 | 3 | 213 | 460,932 | 460.9 K to 460.9 K (0.00 %) |
| Aug 08 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Sell | S | 71.06 | 100 | 7,106 | 460,935 | 461 K to 460.9 K (-0.02 %) |
| Aug 08 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Sell | S | 71.03 | 1,809 | 128,484 | 461,035 | 462.8 K to 461 K (-0.39 %) |
| Aug 08 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Sell | S | 71.01 | 6,779 | 481,343 | 462,844 | 469.6 K to 462.8 K (-1.44 %) |
| Aug 08 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Buy | M | 51.42 | 193,131 | 9,930,796 | 469,623 | 276.5 K to 469.6 K (+69.85 %) |
| Aug 04 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Option Exercise | M | 51.42 | 22,038 | 1,133,194 | 193,131 | |
| Aug 04 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Option Exercise | M | 51.42 | 65,861 | 3,386,573 | 215,169 | |
| Aug 04 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Sell | S | 71.13 | 737 | 52,423 | 276,492 | 277.2 K to 276.5 K (-0.27 %) |
| Aug 04 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Sell | S | 71.11 | 200 | 14,222 | 277,229 | 277.4 K to 277.2 K (-0.07 %) |
| Aug 04 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Sell | S | 71.11 | 500 | 35,553 | 277,429 | 277.9 K to 277.4 K (-0.18 %) |
| Aug 04 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Sell | S | 71.08 | 1,900 | 135,052 | 277,929 | 279.8 K to 277.9 K (-0.68 %) |
| Aug 04 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Sell | S | 71.07 | 3,000 | 213,210 | 279,829 | 282.8 K to 279.8 K (-1.06 %) |
| Aug 04 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Sell | S | 71.06 | 15,600 | 1,108,536 | 282,829 | 298.4 K to 282.8 K (-5.23 %) |
| Aug 04 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Sell | S | 71.00 | 101 | 7,171 | 298,429 | 298.5 K to 298.4 K (-0.03 %) |
| Aug 04 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Sell | S | 71.01 | 35 | 2,485 | 298,530 | 298.6 K to 298.5 K (-0.01 %) |
| Aug 04 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Sell | S | 71.00 | 65,826 | 4,673,646 | 298,565 | 364.4 K to 298.6 K (-18.06 %) |
| Aug 04 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Buy | M | 51.42 | 22,038 | 1,133,194 | 364,391 | 342.4 K to 364.4 K (+6.44 %) |
| Aug 04 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Buy | M | 51.42 | 65,861 | 3,386,573 | 342,353 | 276.5 K to 342.4 K (+23.82 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.45 | 200 | 14,090 | 83,437 | 83.6 K to 83.4 K (-0.24 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.37 | 100 | 7,037 | 83,637 | 83.7 K to 83.6 K (-0.12 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.34 | 100 | 7,034 | 83,737 | 83.8 K to 83.7 K (-0.12 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.29 | 100 | 7,029 | 83,837 | 83.9 K to 83.8 K (-0.12 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.25 | 200 | 14,050 | 83,937 | 84.1 K to 83.9 K (-0.24 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.23 | 600 | 42,138 | 84,137 | 84.7 K to 84.1 K (-0.71 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.22 | 400 | 28,088 | 84,737 | 85.1 K to 84.7 K (-0.47 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.21 | 700 | 49,147 | 85,137 | 85.8 K to 85.1 K (-0.82 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.20 | 500 | 35,100 | 85,837 | 86.3 K to 85.8 K (-0.58 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.19 | 1,200 | 84,228 | 86,337 | 87.5 K to 86.3 K (-1.37 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.19 | 300 | 21,056 | 87,537 | 87.8 K to 87.5 K (-0.34 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.18 | 500 | 35,090 | 87,837 | 88.3 K to 87.8 K (-0.57 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.18 | 200 | 14,035 | 88,337 | 88.5 K to 88.3 K (-0.23 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.17 | 400 | 28,068 | 88,537 | 88.9 K to 88.5 K (-0.45 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.16 | 600 | 42,096 | 88,937 | 89.5 K to 88.9 K (-0.67 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.15 | 100 | 7,015 | 89,537 | 89.6 K to 89.5 K (-0.11 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.14 | 100 | 7,014 | 89,637 | 89.7 K to 89.6 K (-0.11 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.13 | 800 | 56,104 | 89,737 | 90.5 K to 89.7 K (-0.88 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.12 | 700 | 49,084 | 90,537 | 91.2 K to 90.5 K (-0.77 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.12 | 200 | 14,023 | 91,237 | 91.4 K to 91.2 K (-0.22 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.11 | 1,000 | 70,110 | 91,437 | 92.4 K to 91.4 K (-1.08 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.10 | 400 | 28,040 | 92,437 | 92.8 K to 92.4 K (-0.43 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.09 | 100 | 7,009 | 92,837 | 92.9 K to 92.8 K (-0.11 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.08 | 100 | 7,008 | 92,937 | 93 K to 92.9 K (-0.11 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.07 | 400 | 28,028 | 93,037 | 93.4 K to 93 K (-0.43 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.05 | 100 | 7,005 | 93,437 | 93.5 K to 93.4 K (-0.11 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.04 | 300 | 21,012 | 93,537 | 93.8 K to 93.5 K (-0.32 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.02 | 600 | 42,012 | 93,837 | 94.4 K to 93.8 K (-0.64 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.01 | 1,537 | 107,605 | 94,437 | 96 K to 94.4 K (-1.60 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.01 | 100 | 7,001 | 95,974 | 96.1 K to 96 K (-0.10 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.00 | 5,663 | 396,410 | 96,074 | 101.7 K to 96.1 K (-5.57 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | RAPP EDWARD J | Director | Buy | P | 70.45 | 4,000 | 281,782 | 15,498 | 11.5 K to 15.5 K (+34.79 %) |
| Jul 05 2017 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Option Exercise | A | 0.00 | 90 | 0 | 5,491 | |
| Jul 05 2017 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Option Exercise | A | 0.00 | 517 | 0 | 27,970 | |
| Jul 05 2017 | ABBV | AbbVie Inc. | LIDDY EDWARD M | Director | Option Exercise | A | 0.00 | 430 | 0 | 18,688 | |
| Jul 05 2017 | ABBV | AbbVie Inc. | RAPP EDWARD J | Director | Option Exercise | A | 0.00 | 451 | 0 | 11,498 | |
| Jun 30 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Gift | G | 0.00 | 2,235 | 0 | 276,492 | 278.7 K to 276.5 K (-0.80 %) |
| Jun 15 2017 | ABBV | AbbVie Inc. | Schumacher Laura J | Executive Vice Pres ... | Option Exercise | M | 29.23 | 79,800 | 2,332,275 | 0 | |
| Jun 15 2017 | ABBV | AbbVie Inc. | Schumacher Laura J | Executive Vice Pres ... | Sell | S | 70.00 | 79,800 | 5,586,000 | 107,825 | 187.6 K to 107.8 K (-42.53 %) |
| Jun 15 2017 | ABBV | AbbVie Inc. | Schumacher Laura J | Executive Vice Pres ... | Buy | M | 29.23 | 79,800 | 2,332,275 | 187,625 | 107.8 K to 187.6 K (+74.01 %) |
| Jun 15 2017 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Option Exercise | M | 24.21 | 45,800 | 1,108,736 | 0 | |
| Jun 15 2017 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Sell | S | 70.00 | 45,800 | 3,206,000 | 114,745 | 160.5 K to 114.7 K (-28.53 %) |
| Jun 15 2017 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Buy | M | 24.21 | 45,800 | 1,108,736 | 160,545 | 114.7 K to 160.5 K (+39.91 %) |
| Jun 05 2017 | ABBV | AbbVie Inc. | SEVERINO MICHAEL | EVP, R&D and CSO | Payment of Exercise | F | 66.71 | 21,576 | 1,439,335 | 140,555 | 162.1 K to 140.6 K (-13.31 %) |
| May 23 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Sell | S | 65.52 | 1,100 | 72,067 | 278,727 | 279.8 K to 278.7 K (-0.39 %) |
| May 23 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Sell | S | 65.51 | 1,300 | 85,163 | 279,827 | 281.1 K to 279.8 K (-0.46 %) |
| May 23 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Sell | S | 65.51 | 700 | 45,855 | 281,127 | 281.8 K to 281.1 K (-0.25 %) |
| May 23 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Sell | S | 65.51 | 30,549 | 2,001,112 | 281,827 | 312.4 K to 281.8 K (-9.78 %) |
| May 23 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Sell | S | 65.50 | 200 | 13,100 | 312,376 | 312.6 K to 312.4 K (-0.06 %) |
| May 23 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Sell | S | 65.50 | 1,600 | 104,792 | 312,576 | 314.2 K to 312.6 K (-0.51 %) |
| May 23 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Sell | S | 65.49 | 800 | 52,392 | 314,176 | 315 K to 314.2 K (-0.25 %) |
| May 23 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Sell | S | 65.49 | 8,175 | 535,340 | 314,976 | 323.2 K to 315 K (-2.53 %) |
| May 23 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Sell | S | 65.48 | 600 | 39,288 | 323,151 | 323.8 K to 323.2 K (-0.19 %) |
| May 23 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Sell | S | 65.48 | 8,100 | 530,348 | 323,751 | 331.9 K to 323.8 K (-2.44 %) |
| May 23 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Sell | S | 65.47 | 1,400 | 91,658 | 331,851 | 333.3 K to 331.9 K (-0.42 %) |
| May 23 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Sell | S | 65.47 | 14,011 | 917,230 | 333,251 | 347.3 K to 333.3 K (-4.03 %) |
| May 23 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Sell | S | 65.46 | 700 | 45,822 | 347,262 | 348 K to 347.3 K (-0.20 %) |
| May 23 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Sell | S | 65.46 | 600 | 39,273 | 347,962 | 348.6 K to 348 K (-0.17 %) |
| May 23 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Sell | S | 65.45 | 600 | 39,270 | 348,562 | 349.2 K to 348.6 K (-0.17 %) |
| May 23 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Sell | S | 65.45 | 300 | 19,634 | 349,162 | 349.5 K to 349.2 K (-0.09 %) |
| May 23 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Sell | S | 65.44 | 500 | 32,720 | 349,462 | 350 K to 349.5 K (-0.14 %) |
| May 19 2017 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Option Exercise | M | 28.13 | 12,800 | 360,064 | 0 | |
| May 19 2017 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Option Exercise | M | 28.86 | 25,500 | 735,930 | 0 | |
| May 19 2017 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Sell | S | 65.35 | 38,300 | 2,502,905 | 183,543 | 221.8 K to 183.5 K (-17.26 %) |
| May 19 2017 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Buy | M | 28.13 | 12,800 | 360,064 | 221,843 | 209 K to 221.8 K (+6.12 %) |
| May 19 2017 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Buy | M | 28.86 | 25,500 | 735,930 | 209,043 | 183.5 K to 209 K (+13.89 %) |
| May 09 2017 | ABBV | AbbVie Inc. | WADDELL FREDERICK H | Director | Grant | A | 0.00 | 2,770 | 0 | 15,230 | 12.5 K to 15.2 K (+22.23 %) |
| May 09 2017 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Grant | A | 0.00 | 2,770 | 0 | 32,436 | 29.7 K to 32.4 K (+9.34 %) |
| May 09 2017 | ABBV | AbbVie Inc. | RAPP EDWARD J | Director | Grant | A | 0.00 | 2,770 | 0 | 15,730 | 13 K to 15.7 K (+21.37 %) |
| May 09 2017 | ABBV | AbbVie Inc. | MEYER MELODY B | Director | Grant | A | 0.00 | 2,770 | 0 | 2,770 | 0 to 2.8 K |
| May 09 2017 | ABBV | AbbVie Inc. | LIDDY EDWARD M | Director | Grant | A | 0.00 | 2,770 | 0 | 18,351 | 15.6 K to 18.4 K (+17.78 %) |
| May 09 2017 | ABBV | AbbVie Inc. | Hart Brett J | Director | Grant | A | 0.00 | 2,770 | 0 | 5,744 | 3 K to 5.7 K (+93.14 %) |
| May 09 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Gift | G | 0.00 | 4,181 | 0 | 345,781 | 350 K to 345.8 K (-1.19 %) |
| May 09 2017 | ABBV | AbbVie Inc. | BURNSIDE WILLIAM H.L. | Director | Grant | A | 0.00 | 2,770 | 0 | 13,230 | 10.5 K to 13.2 K (+26.48 %) |
| May 09 2017 | ABBV | AbbVie Inc. | AUSTIN ROXANNE S | Director | Grant | A | 0.00 | 2,770 | 0 | 36,296 | 33.5 K to 36.3 K (+8.26 %) |
| May 09 2017 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Grant | A | 0.00 | 2,770 | 0 | 21,789 | 19 K to 21.8 K (+14.56 %) |
| May 08 2017 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Sell | S | 67.00 | 43,000 | 2,881,000 | 114,745 | 157.7 K to 114.7 K (-27.26 %) |
| Apr 04 2017 | ABBV | AbbVie Inc. | TILTON GLENN F | Director | Option Exercise | A | 0.00 | 575 | 0 | 27,191 | |
| Apr 04 2017 | ABBV | AbbVie Inc. | RAPP EDWARD J | Director | Option Exercise | A | 0.00 | 502 | 0 | 10,941 | |
| Apr 04 2017 | ABBV | AbbVie Inc. | LIDDY EDWARD M | Director | Option Exercise | A | 0.00 | 479 | 0 | 18,083 | |
| Apr 04 2017 | ABBV | AbbVie Inc. | Alpern Robert J | Director | Option Exercise | A | 0.00 | 100 | 0 | 5,349 | |
| Mar 30 2017 | ABBV | AbbVie Inc. | AbbVie Inc. | 10% Owner | Sell | S | 22.50 | 450,000 | 10,125,000 | 1,190,473 | 1.6 M to 1.2 M (-27.43 %) |
| Mar 10 2017 | ABBV | AbbVie Inc. | Michael Robert A. | VP, Controller | Sell | S | 65.29 | 5,132 | 335,068 | 16,706 | 21.8 K to 16.7 K (-23.50 %) |
| Mar 10 2017 | ABBV | AbbVie Inc. | Schumacher Laura J | Executive Vice Pres ... | Sell | S | 65.30 | 600 | 39,180 | 107,825 | 108.4 K to 107.8 K (-0.55 %) |
| Mar 10 2017 | ABBV | AbbVie Inc. | Schumacher Laura J | Executive Vice Pres ... | Sell | S | 65.30 | 100 | 6,530 | 108,425 | 108.5 K to 108.4 K (-0.09 %) |
| Mar 10 2017 | ABBV | AbbVie Inc. | Schumacher Laura J | Executive Vice Pres ... | Sell | S | 65.29 | 9,816 | 640,887 | 108,525 | 118.3 K to 108.5 K (-8.29 %) |
| Mar 10 2017 | ABBV | AbbVie Inc. | Schumacher Laura J | Executive Vice Pres ... | Sell | S | 65.28 | 2,300 | 150,144 | 118,341 | 120.6 K to 118.3 K (-1.91 %) |
| Mar 10 2017 | ABBV | AbbVie Inc. | Schumacher Laura J | Executive Vice Pres ... | Sell | S | 65.27 | 15,491 | 1,011,098 | 120,641 | 136.1 K to 120.6 K (-11.38 %) |
| Mar 10 2017 | ABBV | AbbVie Inc. | Schumacher Laura J | Executive Vice Pres ... | Sell | S | 65.24 | 230 | 15,005 | 136,132 | 136.4 K to 136.1 K (-0.17 %) |
| Mar 10 2017 | ABBV | AbbVie Inc. | Schumacher Laura J | Executive Vice Pres ... | Sell | S | 65.22 | 300 | 19,566 | 136,362 | 136.7 K to 136.4 K (-0.22 %) |
| Mar 10 2017 | ABBV | AbbVie Inc. | Schumacher Laura J | Executive Vice Pres ... | Sell | S | 65.21 | 9,696 | 632,276 | 136,662 | 146.4 K to 136.7 K (-6.62 %) |
| Mar 10 2017 | ABBV | AbbVie Inc. | Schumacher Laura J | Executive Vice Pres ... | Sell | S | 65.20 | 100 | 6,520 | 146,358 | 146.5 K to 146.4 K (-0.07 %) |
| Mar 10 2017 | ABBV | AbbVie Inc. | Schumacher Laura J | Executive Vice Pres ... | Sell | S | 65.17 | 100 | 6,517 | 146,458 | 146.6 K to 146.5 K (-0.07 %) |
| Mar 10 2017 | ABBV | AbbVie Inc. | Schumacher Laura J | Executive Vice Pres ... | Sell | S | 65.16 | 757 | 49,326 | 146,558 | 147.3 K to 146.6 K (-0.51 %) |
| Mar 10 2017 | ABBV | AbbVie Inc. | Schumacher Laura J | Executive Vice Pres ... | Sell | S | 65.13 | 100 | 6,513 | 147,315 | 147.4 K to 147.3 K (-0.07 %) |
| Mar 10 2017 | ABBV | AbbVie Inc. | Schumacher Laura J | Executive Vice Pres ... | Sell | S | 65.11 | 410 | 26,695 | 147,415 | 147.8 K to 147.4 K (-0.28 %) |
| Mar 10 2017 | ABBV | AbbVie Inc. | RICHMOND TIMOTHY J. | SVP, Human Resource ... | Sell | S | 65.29 | 22,451 | 1,465,826 | 26,078 | 48.5 K to 26.1 K (-46.26 %) |
| Mar 10 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Option Exercise | M | 29.23 | 53,650 | 1,568,002 | 0 | |
| Mar 10 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Option Exercise | M | 24.21 | 18,366 | 444,608 | 0 | |
| Mar 10 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Gift | G | 0.00 | 785 | 0 | 349,962 | 350.7 K to 350 K (-0.22 %) |
| Mar 10 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Sell | S | 64.25 | 72,016 | 4,627,028 | 350,747 | 422.8 K to 350.7 K (-17.03 %) |
| Mar 10 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Buy | M | 29.23 | 53,650 | 1,568,002 | 422,763 | 369.1 K to 422.8 K (+14.53 %) |
| Mar 10 2017 | ABBV | AbbVie Inc. | GONZALEZ RICHARD A | Chairman of the Boa ... | Buy | M | 24.21 | 18,366 | 444,608 | 369,113 | 350.7 K to 369.1 K (+5.24 %) |
| Feb 21 2017 | ABBV | AbbVie Inc. | AbbVie Inc. | 10% Owner | Option Exercise | C | 0.00 | 1,505,241 | 0 | 0 | |
| Feb 21 2017 | ABBV | AbbVie Inc. | AbbVie Inc. | 10% Owner | Buy | C | 0.00 | 1,505,241 | 0 | 1,640,473 | 135.2 K to 1.6 M (+1,113.08 %) |
| Feb 21 2017 | ABBV | AbbVie Inc. | SEVERINO MICHAEL | EVP, R&D and CSO | Option Exercise | A | 61.36 | 100,100 | 6,142,136 | 100,100 | |
| Feb 21 2017 | ABBV | AbbVie Inc. | SEVERINO MICHAEL | EVP, R&D and CSO | Grant | A | 0.00 | 15,375 | 0 | 192,830 | 177.5 K to 192.8 K (+8.66 %) |
| Feb 21 2017 | ABBV | AbbVie Inc. | SEVERINO MICHAEL | EVP, R&D and CSO | Grant | A | 0.00 | 34,173 | 0 | 177,455 | 143.3 K to 177.5 K (+23.85 %) |
| Feb 21 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Option Exercise | A | 61.36 | 78,340 | 4,806,942 | 78,340 | |
| Feb 21 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Grant | A | 0.00 | 14,035 | 0 | 122,410 | 108.4 K to 122.4 K (+12.95 %) |
| Feb 21 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Grant | A | 0.00 | 31,196 | 0 | 108,375 | 77.2 K to 108.4 K (+40.42 %) |
| Feb 21 2017 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Option Exercise | A | 61.36 | 100,100 | 6,142,136 | 100,100 | |
| Feb 21 2017 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Grant | A | 0.00 | 15,945 | 0 | 223,755 | 207.8 K to 223.8 K (+7.67 %) |
| Feb 21 2017 | ABBV | AbbVie Inc. | CHASE WILLIAM J | EVP, Chief Financia ... | Grant | A | 0.00 | 35,440 | 0 | 207,810 | 172.4 K to 207.8 K (+20.56 %) |
| Feb 21 2017 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Option Exercise | A | 61.36 | 95,750 | 5,875,220 | 95,750 | |
| Feb 21 2017 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Grant | A | 0.00 | 13,350 | 0 | 192,466 | 179.1 K to 192.5 K (+7.45 %) |
| Feb 21 2017 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Grant | A | 0.00 | 29,672 | 0 | 179,116 | 149.4 K to 179.1 K (+19.85 %) |
| Feb 03 2017 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Option Exercise | M | 27.29 | 2,400 | 65,496 | 0 | |
| Feb 03 2017 | ABBV | AbbVie Inc. | SALEKI-GERHARDT AZITA | SVP, Operations | Payment of Exercise | F | 60.89 | 1,558 | 94,867 | 3,873 | 5.4 K to 3.9 K (-28.69 %) |